Bodhi Tree Biotech Files 10-Q for Q2 2025

Ticker: BDTB · Form: 10-Q · Filed: May 20, 2025 · CIK: 2041531

Sentiment: neutral

Topics: 10-Q, quarterly-report, biotechnology

TL;DR

Bodhi Tree Biotech filed its Q2 2025 10-Q. All systems go.

AI Summary

Bodhi Tree Biotechnology Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers the second quarter of their fiscal year, which began on October 1, 2024. The company is incorporated in Delaware and operates in the management consulting services sector.

Why It Matters

This filing provides a quarterly update on Bodhi Tree Biotechnology Inc.'s financial performance and operational status, crucial for investors and stakeholders to assess the company's trajectory.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report with no immediate red flags or significant new information presented in the header.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is March 31, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed on May 20, 2025.

What is Bodhi Tree Biotechnology Inc.'s Standard Industrial Classification code?

Bodhi Tree Biotechnology Inc.'s Standard Industrial Classification code is 8742, which corresponds to SERVICES-MANAGEMENT CONSULTING SERVICES.

In which state is Bodhi Tree Biotechnology Inc. incorporated?

Bodhi Tree Biotechnology Inc. is incorporated in Delaware (DE).

What is the fiscal year end for Bodhi Tree Biotechnology Inc.?

The fiscal year end for Bodhi Tree Biotechnology Inc. is September 30 (0930).

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Bodhi Tree Biotechnology Inc (BDTB).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing